Posted by Michael Wonder on 21 Jun 2021
TGA not expecting Novavax quality data until September
20 June 2021 - Australian’s medicines regulator says it does not expect key data from the country’s third major COVID-19 vaccine hopeful Novavax to land before September after delays to the company’s global regulatory filings.
The nation’s vaccine strategy is once again under scrutiny after the technical advisory group on immunisation updated guidance that Pfizer is the preferred vaccine for under 60s, instead of under 50s.
